-
3
-
-
77954219293
-
Synergism between immunostimulation and prevention of surgery-induced immune suppression: an approach to reduce post-operative tumor progression
-
Avraham R. Benish M. Inbar S. Bartal I. Rosenne E. Ben-Eliyahu S. (2010) Synergism between immunostimulation and prevention of surgery-induced immune suppression: an approach to reduce post-operative tumor progression. Brain Behav Immun 24: 952–958.
-
(2010)
Brain Behav Immun
, vol.24
, pp. 952-958
-
-
Avraham, R.1
Benish, M.2
Inbar, S.3
Bartal, I.4
Rosenne, E.5
Ben-Eliyahu, S.6
-
4
-
-
0030130471
-
Evidence for functional beta-adrenoceptor subtypes in CG-5 breast cancer cell
-
Badino G.R. Novelli A. Girardi C. Di Carlo F. (1996) Evidence for functional beta-adrenoceptor subtypes in CG-5 breast cancer cell. Pharmacol Res 33: 255–260.
-
(1996)
Pharmacol Res
, vol.33
, pp. 255-260
-
-
Badino, G.R.1
Novelli, A.2
Girardi, C.3
Di Carlo, F.4
-
6
-
-
46149121727
-
Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis
-
Benish M. Bartal I. Goldfarb Y. Levi B. Avraham R. Raz A. et al. (2008) Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 15: 2042–2052.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 2042-2052
-
-
Benish, M.1
Bartal, I.2
Goldfarb, Y.3
Levi, B.4
Avraham, R.5
Raz, A.6
-
7
-
-
0036654586
-
Beta-adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines
-
Cakir Y. Plummer H.K. III Tithof P.K. Schuller H.M. (2002) Beta-adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines. Int J Oncol 21: 153–157.
-
(2002)
Int J Oncol
, vol.21
, pp. 153-157
-
-
Cakir, Y.1
Plummer, H.K.2
Tithof, P.K.3
Schuller, H.M.4
-
8
-
-
34249931195
-
A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway
-
Carie A.E. Sebti S.M. (2007) A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway. Oncogene 26: 3777–3788.
-
(2007)
Oncogene
, vol.26
, pp. 3777-3788
-
-
Carie, A.E.1
Sebti, S.M.2
-
9
-
-
48649108278
-
Do stress-related psychosocial factors contribute to cancer incidence and survival?
-
Chida Y. Hamer M. Wardle J. Steptoe A. (2008) Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol 5: 466–475.
-
(2008)
Nat Clin Pract Oncol
, vol.5
, pp. 466-475
-
-
Chida, Y.1
Hamer, M.2
Wardle, J.3
Steptoe, A.4
-
10
-
-
0025742901
-
Beta-adrenergic receptors in human breast cancer: identification, characterization and correlation with progesterone and estradiol receptors
-
Draoui A. Vandewalle B. Hornez L. Revillion F. Lefebvre J. (1991) Beta-adrenergic receptors in human breast cancer: identification, characterization and correlation with progesterone and estradiol receptors. Anticancer Res 11: 677–680.
-
(1991)
Anticancer Res
, vol.11
, pp. 677-680
-
-
Draoui, A.1
Vandewalle, B.2
Hornez, L.3
Revillion, F.4
Lefebvre, J.5
-
12
-
-
1642325724
-
Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters
-
Entschladen F. Drell T.L. IV Lang K. Joseph J. Zaenker K.S. (2004) Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. Lancet Oncol 5: 254–258.
-
(2004)
Lancet Oncol
, vol.5
, pp. 254-258
-
-
Entschladen, F.1
Drell, T.L.2
Lang, K.3
Joseph, J.4
Zaenker, K.S.5
-
13
-
-
79960133993
-
Expanding our therapeutic options: beta blockers for breast cancer?
-
Ganz P.A. Cole S.W. (2011) Expanding our therapeutic options: beta blockers for breast cancer? J Clin Oncol 29: 2612–2616.
-
(2011)
J Clin Oncol
, vol.29
, pp. 2612-2616
-
-
Ganz, P.A.1
Cole, S.W.2
-
14
-
-
80052608472
-
Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort
-
Ganz P.A. Habel L.A. Weltzien E.K. Caan B.J. Cole S.W. (2011) Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat 129: 549–556.
-
(2011)
Breast Cancer Res Treat
, vol.129
, pp. 549-556
-
-
Ganz, P.A.1
Habel, L.A.2
Weltzien, E.K.3
Caan, B.J.4
Cole, S.W.5
-
15
-
-
77951928147
-
Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor
-
Glasner A. Avraham R. Rosenne E. Benish M. Zmora O. Shemer S. et al. (2010) Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol 184: 2449–2457.
-
(2010)
J Immunol
, vol.184
, pp. 2449-2457
-
-
Glasner, A.1
Avraham, R.2
Rosenne, E.3
Benish, M.4
Zmora, O.5
Shemer, S.6
-
17
-
-
70350418226
-
Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol
-
Guo K. Ma Q. Wang L. Hu H. Li J. Zhang D. et al. (2009) Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol. Oncol Rep 22: 825–830.
-
(2009)
Oncol Rep
, vol.22
, pp. 825-830
-
-
Guo, K.1
Ma, Q.2
Wang, L.3
Hu, H.4
Li, J.5
Zhang, D.6
-
18
-
-
35948981785
-
Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer
-
Landen C.N. Jr Lin Y.G. Armaiz Pena G.N. Das P.D. Arevalo J.M. Kamat A.A. et al. (2007) Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Res 67: 10389–10396.
-
(2007)
Cancer Res
, vol.67
, pp. 10389-10396
-
-
Landen, C.N.1
Lin, Y.G.2
Armaiz Pena, G.N.3
Das, P.D.4
Arevalo, J.M.5
Kamat, A.A.6
-
19
-
-
4544321026
-
Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs
-
Lang K. Drell T.L. IV Lindecke A. Niggemann B. Kaltschmidt C. Zaenker K.S. et al. (2004) Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112: 231–238.
-
(2004)
Int J Cancer
, vol.112
, pp. 231-238
-
-
Lang, K.1
Drell, T.L.2
Lindecke, A.3
Niggemann, B.4
Kaltschmidt, C.5
Zaenker, K.S.6
-
21
-
-
51849102803
-
Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway
-
Liu X. Wu W.K.K. Yu L. Sung J.J.Y. Srivastava G. Zhang S.T. et al. (2008) Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway. J Cell Biochem 105: 53–60.
-
(2008)
J Cell Biochem
, vol.105
, pp. 53-60
-
-
Liu, X.1
Wu, W.K.K.2
Yu, L.3
Sung, J.J.Y.4
Srivastava, G.5
Zhang, S.T.6
-
22
-
-
60649116477
-
Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited
-
Loges S. Mazzone M. Hohensinner P. Carmeliet P. (2009) Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Cancer Cell 15: 167–170.
-
(2009)
Cancer Cell
, vol.15
, pp. 167-170
-
-
Loges, S.1
Mazzone, M.2
Hohensinner, P.3
Carmeliet, P.4
-
23
-
-
10744220803
-
Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines
-
Lutgendorf S.K. Cole S. Costanzo E. Bradley S. Coffin J. Jabbari S. et al. (2003) Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin Cancer Res 9: 4514–4521.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 4514-4521
-
-
Lutgendorf, S.K.1
Cole, S.2
Costanzo, E.3
Bradley, S.4
Coffin, J.5
Jabbari, S.6
-
24
-
-
77956922153
-
Host factors and cancer progression: biobehavioral signaling pathways and interventions
-
Lutgendorf S.K. Sood A.K. Antoni M.H. (2010) Host factors and cancer progression: biobehavioral signaling pathways and interventions. J Clin Oncol 28: 4094–4099.
-
(2010)
J Clin Oncol
, vol.28
, pp. 4094-4099
-
-
Lutgendorf, S.K.1
Sood, A.K.2
Antoni, M.H.3
-
25
-
-
82255180781
-
β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines
-
Madden K.S. Szpunar M.J. Brown E.B. (2011) β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines. Breast Cancer Res Treat 130: 747–758.
-
(2011)
Breast Cancer Res Treat
, vol.130
, pp. 747-758
-
-
Madden, K.S.1
Szpunar, M.J.2
Brown, E.B.3
-
26
-
-
0025979671
-
A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: hormonal control of beta-adrenergic receptors and correlation with tumor growth
-
Marchetti B. Spinola P.G. Pelletier G. Labrie F. (1991) A potential role for catecholamines in the development and progression of carcinogen-induced mammary tumors: hormonal control of beta-adrenergic receptors and correlation with tumor growth. J Steroid Biochem Mol Biol 38: 307–320.
-
(1991)
J Steroid Biochem Mol Biol
, vol.38
, pp. 307-320
-
-
Marchetti, B.1
Spinola, P.G.2
Pelletier, G.3
Labrie, F.4
-
27
-
-
0035300538
-
Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers
-
Masur K. Niggemann B. Zanker K.S. Entschladen F. (2001) Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res 61: 2866–2869.
-
(2001)
Cancer Res
, vol.61
, pp. 2866-2869
-
-
Masur, K.1
Niggemann, B.2
Zanker, K.S.3
Entschladen, F.4
-
28
-
-
12344326829
-
Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor
-
Melamed R. Rosenne E. Shakhar K. Schwartz Y. Abudarham N. Ben-Eliyahu S. (2005) Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor. Brain Behav Immun 19: 114–126.
-
(2005)
Brain Behav Immun
, vol.19
, pp. 114-126
-
-
Melamed, R.1
Rosenne, E.2
Shakhar, K.3
Schwartz, Y.4
Abudarham, N.5
Ben-Eliyahu, S.6
-
30
-
-
33646371479
-
The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB / c nude mice is inhibited by beta-blockers
-
Palm D. Lang K. Niggemann B. Drell T.L. IV Masur K. Zaenker K.S. et al (2006) The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB / c nude mice is inhibited by beta-blockers. Int J Cancer 118: 2744–2749.
-
(2006)
Int J Cancer
, vol.118
, pp. 2744-2749
-
-
Palm, D.1
Lang, K.2
Niggemann, B.3
Drell, T.L.4
Masur, K.5
Zaenker, K.S.6
-
31
-
-
79953223742
-
Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism
-
Park S.Y. Kang J.H. Jeong K.J. Lee J. Han J.W. Choi W.S. et al (2011) Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism. Int J Cancer 128: 2306–2316.
-
(2011)
Int J Cancer
, vol.128
, pp. 2306-2316
-
-
Park, S.Y.1
Kang, J.H.2
Jeong, K.J.3
Lee, J.4
Han, J.W.5
Choi, W.S.6
-
33
-
-
82955197460
-
Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study
-
Powe D.G. Voss M.J. Habashy H.O. Zänker K.S. Green A.R. Ellis I.O. et al. (2011) Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study. Breast Cancer Res Treat 130: 457–463.
-
(2011)
Breast Cancer Res Treat
, vol.130
, pp. 457-463
-
-
Powe, D.G.1
Voss, M.J.2
Habashy, H.O.3
Zänker, K.S.4
Green, A.R.5
Ellis, I.O.6
-
34
-
-
77955557855
-
Beta-blocker treatment is associated with a reduction in tumour metastasis and an improvement in specific survival in patients with breast cancer
-
Powe D.G. Voss M.J. Habashy K.S. Zänker K.S. Green A.R. Ellis I.O. et al (2010 a) Beta-blocker treatment is associated with a reduction in tumour metastasis and an improvement in specific survival in patients with breast cancer. EJC Suppl 8: 188–189.
-
(2010)
EJC Suppl
, vol.8
, pp. 188-189
-
-
Powe, D.G.1
Voss, M.J.2
Habashy, K.S.3
Zänker, K.S.4
Green, A.R.5
Ellis, I.O.6
-
35
-
-
79953658412
-
Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival
-
Powe D.G. Voss M.J. Zänker K.S. Habashy H.O. Green A.R. Ellis I.O. et al (2010 b) Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget 1: 628–638.
-
(2010)
Oncotarget
, vol.1
, pp. 628-638
-
-
Powe, D.G.1
Voss, M.J.2
Zänker, K.S.3
Habashy, H.O.4
Green, A.R.5
Ellis, I.O.6
-
36
-
-
0027076822
-
Effects of a beta 2-agonist (clenbuterol) on cultured human (CG-5) breast cancer cells
-
Re G. Badino P. Girardi C. Di Carlo F. 1992. Effects of a beta 2-agonist (clenbuterol) on cultured human (CG-5) breast cancer cells. Pharmacol Res 26: 377–384.
-
(1992)
Pharmacol Res
, vol.26
, pp. 377-384
-
-
Re, G.1
Badino, P.2
Girardi, C.3
Di Carlo, F.4
-
37
-
-
34347206025
-
Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation
-
Sastry K.S.R. Karpova Y. Prokopovich S. Smith A.J. Essau B. Gersappe A. et al. (2007) Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. J Biol Chem 282: 14094–14100.
-
(2007)
J Biol Chem
, vol.282
, pp. 14094-14100
-
-
Sastry, K.S.R.1
Karpova, Y.2
Prokopovich, S.3
Smith, A.J.4
Essau, B.5
Gersappe, A.6
-
39
-
-
84856363535
-
Can all beta blockers improve the breast cancer survival?
-
Sendur M.A.N. Aksoy S. Yaman S. Arik Z. Altundag K. (2012) Can all beta blockers improve the breast cancer survival? Breast 21 (1): 107–108.
-
(2012)
Breast
, vol.21
, Issue.1
, pp. 107-108
-
-
Sendur, M.A.N.1
Aksoy, S.2
Yaman, S.3
Arik, Z.4
Altundag, K.5
-
40
-
-
79958717592
-
Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study
-
Shah S.M. Carey I.M. Owen C.G. Harris T. Dewilde S. Cook D.G. (2011) Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study. Br J Clin Pharmacol 72: 157–161.
-
(2011)
Br J Clin Pharmacol
, vol.72
, pp. 157-161
-
-
Shah, S.M.1
Carey, I.M.2
Owen, C.G.3
Harris, T.4
Dewilde, S.5
Cook, D.G.6
-
41
-
-
80955180176
-
β2-Adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction
-
Shan T. Ma Q. Zhang D. Guo K. Liu H. Wang F. et al. (2011) β2-Adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction. Eur J Pharmacol 665: 1–7.
-
(2011)
Eur J Pharmacol
, vol.665
, pp. 1-7
-
-
Shan, T.1
Ma, Q.2
Zhang, D.3
Guo, K.4
Liu, H.5
Wang, F.6
-
42
-
-
78650987645
-
The β2-adrenergic receptor and Her 2 comprise a positive feedback loop in human breast cancer cells
-
Shi M. Liu D. Duan H. Qian L. Wang L. Niu L. et al. (2011) The β2-adrenergic receptor and Her 2 comprise a positive feedback loop in human breast cancer cells. Breast Cancer Res Treat 125: 351–362.
-
(2011)
Breast Cancer Res Treat
, vol.125
, pp. 351-362
-
-
Shi, M.1
Liu, D.2
Duan, H.3
Qian, L.4
Wang, L.5
Niu, L.6
-
45
-
-
0032938071
-
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
-
Smith C. Teitler M. (1999) Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors. Cardiovasc Drugs Ther 13: 123–126.
-
(1999)
Cardiovasc Drugs Ther
, vol.13
, pp. 123-126
-
-
Smith, C.1
Teitler, M.2
-
46
-
-
77951863320
-
Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis
-
Sood A.K. Armaiz-Pena G.N. Halder J. Nick A.M. Stone R.L. Hu W. et al. (2010) Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J Clin Invest 120: 1515–1523.
-
(2010)
J Clin Invest
, vol.120
, pp. 1515-1523
-
-
Sood, A.K.1
Armaiz-Pena, G.N.2
Halder, J.3
Nick, A.M.4
Stone, R.L.5
Hu, W.6
-
48
-
-
34548158944
-
Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial
-
Spiegel D. Butler L.D. Giese-Davis J. Koopman C. Miller E. DiMiceli S. et al. (2007) Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial. Cancer 110: 1130–1138.
-
(2007)
Cancer
, vol.110
, pp. 1130-1138
-
-
Spiegel, D.1
Butler, L.D.2
Giese-Davis, J.3
Koopman, C.4
Miller, E.5
DiMiceli, S.6
-
49
-
-
77954867089
-
Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action
-
Storch C.H. Hoeger P.H. (2010) Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 163: 269–274.
-
(2010)
Br J Dermatol
, vol.163
, pp. 269-274
-
-
Storch, C.H.1
Hoeger, P.H.2
-
50
-
-
33746851955
-
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
-
Thaker P.H. Han L.Y. Kamat A.A. Arevalo J.M. Takahashi R. Lu C. et al. (2006) Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12: 939–944.
-
(2006)
Nat Med
, vol.12
, pp. 939-944
-
-
Thaker, P.H.1
Han, L.Y.2
Kamat, A.A.3
Arevalo, J.M.4
Takahashi, R.5
Lu, C.6
-
51
-
-
33847780915
-
The neuroendocrine impact of chronic stress on cancer
-
Thaker P.H. Lutgendorf S.K. Sood A.K. (2007) The neuroendocrine impact of chronic stress on cancer. Cell Cycle 6: 430–433.
-
(2007)
Cell Cycle
, vol.6
, pp. 430-433
-
-
Thaker, P.H.1
Lutgendorf, S.K.2
Sood, A.K.3
-
53
-
-
38649091370
-
VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine
-
Yang E.V. Donovan E.L. Benson D.M. Glaser R. (2008) VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine. Brain Behav Immun 22: 318–323.
-
(2008)
Brain Behav Immun
, vol.22
, pp. 318-323
-
-
Yang, E.V.1
Donovan, E.L.2
Benson, D.M.3
Glaser, R.4
-
54
-
-
58549084362
-
Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression
-
Yang E.V. Kim S.J. Donovan E.L. Chen M. Gross A.C. Webster Marketon J.I. et al. (2009) Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun 23: 267–275.
-
(2009)
Brain Behav Immun
, vol.23
, pp. 267-275
-
-
Yang, E.V.1
Kim, S.J.2
Donovan, E.L.3
Chen, M.4
Gross, A.C.5
Webster Marketon, J.I.6
-
55
-
-
33751261895
-
Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells
-
Yang E.V. Sood A.K. Chen M. Li Y. Eubank T.D. Marsh C.B. et al. (2006) Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. Cancer Res 66: 10357–10364.
-
(2006)
Cancer Res
, vol.66
, pp. 10357-10364
-
-
Yang, E.V.1
Sood, A.K.2
Chen, M.3
Li, Y.4
Eubank, T.D.5
Marsh, C.B.6
-
56
-
-
59649084222
-
Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell
-
Zhang D. Ma Q. Shen S. Hu H. (2009) Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell. Pancreas 38: 94–100.
-
(2009)
Pancreas
, vol.38
, pp. 94-100
-
-
Zhang, D.1
Ma, Q.2
Shen, S.3
Hu, H.4
-
57
-
-
77954417979
-
β2-Adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1
-
Zhang D. Ma Q.-Y. Hu H.-T. Zhang M. (2010) β2-Adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1. Cancer Biol Ther 10: 19–29.
-
(2010)
Cancer Biol Ther
, vol.10
, pp. 19-29
-
-
Zhang, D.1
Ma, Q.-Y.2
Hu, H.-T.3
Zhang, M.4
|